Global CBD Consumer Health Market by Product (Medical OTC Products, Nutraceuticals), Distribution Channel (Online, Retail Pharmacies, Retail Stores) - Forecast 2023-2030
March 08, 2024 09:31 ET
|
Research and Markets
Dublin, March 08, 2024 (GLOBE NEWSWIRE) -- The "Global CBD Consumer Health Market by Product (Medical OTC Products, Nutraceuticals), Distribution Channel (Online, Retail Pharmacies, Retail Stores) -...
U.S. Controlled Substance Market Size Worth USD 74.3 billion by 2031, Rising at a CAGR of 5.2% - Says Transparency Market Research
September 07, 2023 15:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Sept. 08, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The U.S. controlled substance market is projected to flourish at a CAGR of 5.2% from 2022...
Wake Up Narcolepsy Debuts Public Service Announcement in Collaboration with Red Square Pictures
July 11, 2023 11:17 ET
|
Wake Up Narcolepsy
WORCESTER, Mass., July 11, 2023 (GLOBE NEWSWIRE) -- Wake Up Narcolepsy (WUN), a national leader for research and awareness, premiered its Narcolepsy public service announcement in partnership with Red...
Remote Patient Monitoring Market’s expected worth by 2030 is USD 4.07 billion
June 28, 2022 13:05 ET
|
STRATEGIC MARKET RESEARCH LLP
New York, United States, June 28, 2022 (GLOBE NEWSWIRE) -- The key factors driving the Remote Patient Monitoring Market are the rising number of chronic diseases, increased awareness and a rising...
KemPharm Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Corporate Updates
March 30, 2022 16:05 ET
|
KemPharm
Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Today, March 30, 2022, 5:00 p.m. ET Corporate and Regulatory Highlights Announced strategic focus on developing...
KemPharm Announces Full Data Set from Higher-Dose Serdexmethylphenidate (SDX) Phase 1 Clinical Trial
March 21, 2022 07:30 ET
|
KemPharm
Data demonstrate higher doses of SDX were generally well-tolerated and produced targeted pharmacodynamic effects that may be beneficial for the treatment of idiopathic hypersomnia (IH) and other sleep...
Sleep Disorder Market revenue to cross USD 20.5 Bn by 2027: Global Market Insights Inc.
January 12, 2022 06:30 ET
|
Global Market Insights Inc.
Selbyville, Delaware, Jan. 12, 2022 (GLOBE NEWSWIRE) -- The sleep disorder market size is anticipated to record a valuation of USD 20.5 billion by 2027, according to the most recent study by...
College of DuPage Student Awarded Honors Council of the Illinois Region Research Grant to Study Rare Sleep Disorder
June 16, 2020 10:05 ET
|
College of DuPage
Glen Ellyn, Ill., June 16, 2020 (GLOBE NEWSWIRE) -- College of DuPage Psychology student Savannah Santos was recently awarded a $600 Margaret Messer Student Research Grant from the Honors Council of...
Cure Pharmaceutical Enters Into Product Development Agreement with Therapix Biosciences To Develop Cannabinoid-Based Product For Sleep Disorders
November 07, 2017 09:00 ET
|
CURE Pharmaceutical; Therapix Biosciences Ltd.
OXNARD, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Cure Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology announced today that it has entered into a product...
Zynex Announces First Quarter 2015 Results
May 12, 2015 08:00 ET
|
Zynex, Inc.
LONE TREE, CO--(Marketwired - May 12, 2015) - Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain...